VENLIFT ER 150 MG CAPSULE

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

VENLAFAXINE HYDROCHLORIDE

Boleh didapati daripada:

LABORATORIES TORRENT (MALAYSIA) SDN. BHD.

INN (Nama Antarabangsa):

VENLAFAXINE HYDROCHLORIDE

Unit dalam pakej:

10capsule Capsules; 30capsule Capsules; 100capsule Capsules

Dikeluarkan oleh:

TORRENT PHARMACEUTICALS LTD

Risalah maklumat

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
_ _
VENLIFT ER CAPSULE
Venlafaxine Hydrochloride (37.5mg, 75mg & 150mg)
1
WHAT IS IN THIS LEAFLET
1.
What is VENLIFT ER is used
for
2.
How VENLIFT ER works
3.
Before you use VENLIFT ER
4.
How to use VENLIFT ER
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
VENLIFT ER
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
WHAT VENLIFT ER IS USED FOR
VENLIFT ER are used in treatment
for:
•
Adults with depression
including depression with
associated anxiety, in
hospitalized patients.
•
Anxiety or Generalized
Anxiety Disorder (GAD),
including long term treatment.
•
Prevention of relapse of an
episode of depression or for
prevention of the recurrence of
new depressive episodes.
•
Social Anxiety Disorder, also
known as Social Phobia, as
defined in DSM-IV which are
characterized by a significant
amount of fear in one or more
social situations, causing
considerable distress and
impaired ability to function in
at least some parts of daily life.
•
Panic disorder, including
prevention of relapse.
HOW VENLIFT ER WORKS
VENLIFT ER is an antidepressant
that belongs to a group of medicines
called serotonin and norepinephrine
reuptake inhibitors (SNRIs). This
group of medicines is used to treat
depression and other conditions
such as anxiety disorders help by
increasing the levels of serotonin
and noradrenaline in the brain. It is
thought that people who are
depressed and/or anxious have
lower levels of serotonin and
noradrenaline in the brain.
BEFORE YOU USE VENLIFT ER
-
_When you must not use it _
Do not take VENLIFT ER:
•
If you are allergic to
venlafaxine or any of the other
ingredients of VENLIFT ER.
•
If you are also taking or have
taken anytime within the last
14 days any medicines known
as irreversible monoamine
oxidase inhibitors (MAOIs),
used to treat depression or
Parkinson’s disease. Taking an
irreversible MAOI together
with other medicines,
including VENLIFT ER, can
cause serious or even life-

Ciri produk

PRODUCT NAME
:
ITEM / PACK
:
DESIGN STYLE
:
CODE
:
DIMENSIONS (MM)
:
ART WORK SIZE
:
DATE : 31-03-2022
Reviewed By
NO. OF COLORS: 1
COUNTRY : Malaysia
Front / Back
Venlift ER
Insert
S/S
180 x 330
xxxxxxxxx-5253
Black
PANTONE SHADE NOS.:
ACTIVITIES
DEPARTMENT
NAME
SIGNATURE
DATE
Prepared By
PKG.DEV
PKG.DEV
LOCATION :
Indrad
QUALITY
Approved By
PRODUCT NAME
VENLIFT ER 37.5 MG CAPSULES VENLIFT ER 75 MG CAPSULES
VENLIFT ER 150 MG CAPSULES
NAME AND STRENGTH OF ACTIVE SUBSTANCE(S)
VENLIFT ER 37.5 MG CAPSULES
VENLIFT ER 75 MG CAPSULES
VENLIFT ER 150 MG CAPSULES
Each hard gelatin capsule contains:
Venlafaxine hydrochloride Ph. Eur.
equivalent to Venlafaxine 37.5/75/150 mg
(In the form of extended release pellets)
Approved colors used in hard gelatin capsule shell
Gelatin of Bovine origin
PRODUCT DESCRIPTION
VENLIFT ER 37.5 MG CAPSULES: Size “4” Peach/Translucent Peach,
hard
gelatin capsules, containing white to off-white pellets.
VENLIFT ER 75 MG CAPSULES: Size “2”, Yellow/translucent yellow,
hard gelatin
capsules, containing white to off-white pellets.
VENLIFT ER 150 MG CAPSULES: Size “0”, Orange/translucent orange,
hard
gelatin capsules, containing white to off-white pellets.
DOSAGE FORM
Hard Gelatin Capsule
CLINICAL PHARMACOLOGY
PHARMACODYNAMICS
The mechanism of the antidepressant action of venlafaxine in humans is
believed to
be associated with its potentiation of neurotransmitter activity in
the central nervous
system. Preclinical studies have reported that venlafaxine and its
major metabolite,
O-Desmethyl venlafaxine (ODV), are potent inhibitors of neuronal
serotonin and
norepinephrine reuptake, and weak inhibitors of dopamine reuptake.
Animal
studies reported that tricyclic antidepressants may reduce
β
-adrenergic receptor
responsiveness following chronic administration. In contrast,
venlafaxine and
O-Desmethyl venlafaxine reduce
β
-adrenergic responsiveness after both acute
(single dose) and chronic administration. These results may predict a
more rapid
onset of clinical activity for venlafaxine. Ve